{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:30:27Z","timestamp":1786696227361,"version":"build-2736575974"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity is a chronic, progressive, relapsing disease characterized by excess or dysfunctional adiposity that impairs health and contributes to multimorbidity, disability, and reduced life expectancy. Contemporary international frameworks recommend moving beyond BMI-only definitions toward disease-based diagnostic models that integrate adiposity, complications, and functional status. Croatia faces a high prevalence of obesity alongside constrained healthcare resources and limited reimbursement for modern pharmacotherapy, highlighting the need for nationally adapted clinical guidance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This position statement was developed using a modified Delphi consensus process involving 23 multidisciplinary experts from academic and clinical institutions across Croatia. Consensus statements were derived from contemporary international guidelines, randomized controlled trials, and meta-analyses. Evidence quality and recommendation strength were graded using an adapted GRADE-based framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The document establishes a Croatia-specific framework for the diagnosis, staging, and management of obesity. Diagnosis requires confirmation of excess adiposity with evidence of clinical risk or dysfunction and integrates anthropometric measures with metabolic, mechanical, psychological, and functional domains. A staging system aligned with EASO and Lancet frameworks guides treatment intensity according to disease severity. Management is based on four pillars: lifestyle therapy, psychological support, pharmacotherapy, and metabolic\/bariatric surgery. Pharmacological treatment is stage-based and comorbidity-driven, prioritizing agents with proven organ-protective effects. Special considerations are provided for older adults, emphasizing preservation of muscle mass, functional capacity, independence, and quality of life. Long-term structured follow-up is recommended for all patients, reflecting the chronic disease model of obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This position statement provides an evidence-based, nationally adapted clinical framework that aligns obesity management with modern chronic disease standards. By integrating disease staging, individualized therapy, and long-term care, it supports precision treatment across the lifespan and emphasizes obesity management as a key strategy for preventing complications, reducing disability, and promoting healthy longevity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fragi.2026.1834323","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:07:38Z","timestamp":1786694858000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From obesity to healthy longevity: a consensus-based clinical framework for diagnosis, staging, and treatment"],"prefix":"10.3389","volume":"7","author":[{"given":"Silvija","family":"Canecki-Var\u017ei\u0107","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Clinic of Internal Medicine, Osijek University Hospital Centre","place":["Osijek, Croatia"]},{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]},{"name":"Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Bili\u0107-\u0106ur\u010di\u0107","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Clinic of Internal Medicine, Osijek University Hospital Centre","place":["Osijek, Croatia"]},{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Bakula","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, University Clinic for Diabetes, Endocrinology and Metabolic Diseases Vuk Vrhovac, Merkur University Hospital","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Bulum","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, University Clinic for Diabetes, Endocrinology and Metabolic Diseases Vuk Vrhovac, Merkur University Hospital","place":["Zagreb, Croatia"]},{"name":"Faculty of Medicine, University of Zagreb","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"\u010cavlovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, University Clinic for Diabetes, Endocrinology and Metabolic Diseases Vuk Vrhovac, Merkur University Hospital","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Deli\u0107-Brklja\u010di\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Zagreb","place":["Zagreb, Croatia"]},{"name":"Clinic for Cardiovascular Diseases, Sestre Milosrdnice University Hospital Centre","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara Turk","family":"Wensveen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka","place":["Rijeka, Croatia"]},{"name":"Center for Endocrinology, Diabetes and Cardiometabolism, Clinic for Treatment, Rehabilitation and Prevention of Cardiovascular Diseases, Thalassotherapia Opatija","place":["Opatija, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Fabris-Vitkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, Pula General Hospital","place":["Pula, Croatia"]},{"name":"Faculty of Medicine, Juraj Dobrila University of Pula","place":["Pula, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravka","family":"Juri\u0161i\u0107-Er\u017een","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka","place":["Rijeka, Croatia"]},{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, Rijeka University Hospital Centre","place":["Rijeka, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Klobu\u010dar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka","place":["Rijeka, Croatia"]},{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, Rijeka University Hospital Centre","place":["Rijeka, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Kljaji\u0107","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, University Clinic for Diabetes, Endocrinology and Metabolic Diseases Vuk Vrhovac, Merkur University Hospital","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mladen","family":"Krni\u0107","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolic Disorders, Split University Hospital Centre","place":["Split, Croatia"]},{"name":"Faculty of Medicine, University of Split","place":["Split, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bla\u017eenka","family":"Mi\u0161ki\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]},{"name":"Josip Ben\u010devi\u0107 General Hospital","place":["Slavonski Brod, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Moser","sequence":"additional","affiliation":[{"name":"Josip Ben\u010devi\u0107 General Hospital","place":["Slavonski Brod, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017eidar","family":"Novoselovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases \u201cMladen Sekso\u201d, Sestre Milosrdnice University Hospital Centre","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pe\u0107in","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Zagreb","place":["Zagreb, Croatia"]},{"name":"Department of Metabolic Diseases, Zagreb University Hospital Centre","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Ti\u010dinovi\u0107-Kurir","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolic Disorders, Split University Hospital Centre","place":["Split, Croatia"]},{"name":"Faculty of Medicine, University of Split","place":["Split, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Vu\u010dak-Lon\u010dar","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, Department of Internal Medicine, Zadar General Hospital","place":["Zadar, Croatia"]},{"name":"Department of Health Studies, University of Zadar","place":["Zadar, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Gradi\u0161er","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Split","place":["Split, Croatia"]},{"name":"Department of Internal Medicine, \u010cakovec County Hospital","place":["\u010cakovec, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Cigrovski Berkovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Kinesiology, Department for Sport and Exercise Medicine, University of Zagreb","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorana","family":"Miro\u0161evi\u0107","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases \u201cMladen Sekso\u201d, Sestre Milosrdnice University Hospital Centre","place":["Zagreb, Croatia"]},{"name":"School of Dental Medicine, University of Zagreb","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Selthofer-Relati\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]},{"name":"Department for Heart and Vascular Diseases, Clinic of Internal Medicine, Osijek University Hospital Centre","place":["Osijek, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miro","family":"Bakula","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Zagreb","place":["Zagreb, Croatia"]},{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, Sveti Duh University Hospital","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obes. (Silver Spring)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa1108660","article-title":"Comparative effectiveness of weight-loss interventions in clinical practice","volume":"365","author":"Appel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/s0140-6736(15)00803-x","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE sleep apnea randomized clinical trial","volume":"40","author":"Blackman","year":"2016","journal-title":"Int. J. Obes. (Lond)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/nejmoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","volume":"30","author":"Busetto","year":"2024","journal-title":"Nat. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"B8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1007\/s11695-024-07370-7","article-title":"Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO\/ASMBS)","volume":"34","author":"De Luca","year":"2024","journal-title":"Obes. Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000549751","article-title":"European association for the study of obesity position statement on the diagnosis and management of obesity in older adults","volume":"19","author":"Di Vincenzo","year":"2025","journal-title":"Obes. Facts"},{"key":"B11","doi-asserted-by":"publisher","first-page":"g2646","DOI":"10.1136\/bmj.g2646","article-title":"Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials","volume":"14","author":"Dombrowski","year":"2014","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes. Facts"},{"key":"B13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13063-025-09113-0","article-title":"Investigating the effect of a cognitive-behavioral therapy intervention aimed at reducing weight self-stigma on adherence to weight loss diet and anthropometric indices in adult women with obesity: study protocol for a randomized controlled trial","volume":"26","author":"Fahami","year":"2025","journal-title":"Trials"},{"key":"B14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/sj.ijo.0801128","article-title":"One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor","volume":"24","author":"Finer","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s13679-024-00552-5","article-title":"Behavioral lifestyle interventions for weight loss in overweight or Obese patients with type 2 diabetes: a systematic review of the literature","volume":"13","author":"Gostoli","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"100761","DOI":"10.1016\/j.lanhl.2025.100761","article-title":"Bone quality response to lifestyle intervention in older adults with obesity (LIMG-Q trial): a randomised controlled trial","volume":"6","author":"Gregori","year":"2025","journal-title":"Lancet Healthy Longev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"key":"B18","volume-title":"Overweight and Obesity Management","author":"Guidelines","year":"2025"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.ae","article-title":"GRADE guidelines: going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/obr.12220","article-title":"Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis","volume":"15","author":"Hartmann-Boyce","year":"2014","journal-title":"Obes. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7325973","DOI":"10.1155\/2016\/7325973","article-title":"Osteosarcopenic obesity syndrome: what is it and how can it be identified and diagnosed?","volume":"2016","author":"Ilich","year":"2016","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/nejmoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/nejmoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/s0140-6736(24)01643-x","article-title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/heartjnl-2024-324170","article-title":"Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial","volume":"110","author":"Krumholz","year":"2024","journal-title":"Heart"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41598-023-40141-5","article-title":"Cognitive behavioral therapy for lifestyle changes in patients with obesity and type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Kurnik Mesari\u010d","year":"2023","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/s0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"zsae280","DOI":"10.1093\/sleep\/zsae280","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis","volume":"48","author":"Li","year":"2025","journal-title":"Sleep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"pzaf097","DOI":"10.1093\/ptj\/pzaf097","article-title":"Lifestyle intervention in people with overweight and obesity and chronic low back pain: study protocol for an international multicenter randomized controlled trial","volume":"105","author":"Liechti","year":"2025","journal-title":"Phys. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/nejmoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1030204","DOI":"10.1016\/j.eclinm.2024.103020","article-title":"Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis","volume":"79","author":"Liu","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/nejmoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/nejmoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.nut.2011.12.002","article-title":"What is dynapenia?","volume":"28","author":"Manini","year":"2012","journal-title":"Nutrition"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1038\/s41591-025-03765-w","article-title":"Framework for the pharmacological treatment of obesity and its complications from the european association for the study of obesity (EASO)","volume":"31","author":"McGowan","year":"2025","journal-title":"Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jama.2016.1558","article-title":"Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and Obese patients with cardiovascular risk factors: a randomized clinical trial","volume":"315","author":"Nissen","year":"2016","journal-title":"JAMA"},{"key":"B39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/nejmoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.2337\/dc21-1785","article-title":"Changes in glucose metabolism and glycemic status with once-weekly subcutaneous semaglutide 2.4 mg among participants with prediabetes in the STEP program","volume":"45","author":"Perreault","year":"2022","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/nejmoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of Liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.clnu.2012.06.010","article-title":"Sarcopenic obesity: a critical appraisal of the current evidence","volume":"31","author":"Prado","year":"2012","journal-title":"Clin. Nutr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"B46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.phrs.2017.05.022","article-title":"Effect of orlistat on plasma lipids and body weight: a systematic review and meta-analysis of 33 randomized controlled trials","volume":"122","author":"Sahebkar","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jash.2017.12.002","article-title":"Effects of orlistat on blood pressure: a systematic review and meta-analysis of 27 randomized controlled clinical trials","volume":"12","author":"Sahebkar","year":"2018","journal-title":"J. Am. Soc. Hypertens."},{"key":"B49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13098-024-01371-3","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Salamah","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/nejmoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1038\/s41591-023-02597-w","article-title":"Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial","volume":"29","author":"Wadden","year":"2023","journal-title":"Nat. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e13686","DOI":"10.1111\/obr.13686","article-title":"The effects of incretin-based therapies on weight reduction and metabolic parameters in children with obesity: a systematic review and meta-analysis","volume":"25","author":"Wang","year":"2024","journal-title":"Obes. Rev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/nejmoa2302392","article-title":"Daily oral GLP-1 receptor agonist orforglipron for adults with obesity","volume":"389","author":"Wharton","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/s2213-8587(25)00226-8","article-title":"Once-weekly semaglutide 7\u00b72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","volume":"13","author":"Wharton","year":"","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/nejmoa2500969","article-title":"Oral semaglutide at a dose of 25 mg in adults with overweight or obesity","volume":"393","author":"Wharton","year":"","journal-title":"N. Engl. J. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/nejmoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B59","volume-title":"Guideline on the Use of Glucagon-like peptide-1 (GLP-1) Therapies for the Treatment of Obesity in Adults","year":"2025"}],"container-title":["Frontiers in Aging"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2026.1834323\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:07:39Z","timestamp":1786694859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2026.1834323\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":58,"alternative-id":["10.3389\/fragi.2026.1834323"],"URL":"https:\/\/doi.org\/10.3389\/fragi.2026.1834323","relation":{},"ISSN":["2673-6217"],"issn-type":[{"value":"2673-6217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1834323"}}